Fengyun Pei

Title: Innovations in Colorectal Cancer Treatment by Fengyun Pei

Introduction

Fengyun Pei is a notable inventor based in Guangdong, China. She has made significant contributions to the field of oncology, particularly in the treatment of colorectal cancer. Her innovative approach has led to the development of a pharmaceutical composition that shows promise in treating locally advanced mismatch repair-proficient/microsatellite stable (pMMR/MSS) colorectal cancer.

Latest Patents

Fengyun Pei holds a patent for a pharmaceutical composition aimed at treating locally advanced pMMR/MSS colorectal cancer. The patent details a combination of mFOLFOX6, bevacizumab, and a PD-1 inhibitor. Experimental results indicate that this composition has achieved major pathological remission in 14 out of 18 cases, with a complete pathological response in 10 cases. The treatment has demonstrated a significant reduction in tumor marker levels and has been noted for its safety and efficacy, with no fatal serious adverse events reported.

Career Highlights

Fengyun Pei is affiliated with The Sixth Affiliated Hospital, Sun Yat-Sen University. Her work focuses on developing effective treatments for colorectal cancer, contributing to advancements in medical science and patient care. Her research has the potential to improve the quality of life for patients suffering from this challenging condition.

Collaborations

Fengyun Pei collaborates with esteemed colleagues, including Yanhong Deng and Jianping Wang. Their combined expertise enhances the research and development of innovative cancer treatments.

Conclusion

Fengyun Pei's contributions to the field of oncology, particularly through her patented pharmaceutical composition, represent a significant advancement in the treatment of colorectal cancer. Her work exemplifies the impact of innovation in improving patient outcomes and advancing medical research.